Wolverine 40 — BPC-157 / TB-500 Composite
Dual-Peptide Recovery Research Blend · 40mg Research Vial
Compound Overview
The TR-2 Composite 40mg is an extended-format dual-peptide preparation combining BPC-157 (20mg) and Thymosin Beta-4 Fragment TB-500 (20mg) in a pre-loaded disposable research pen.
BPC-157: A synthetic pentadecapeptide (15 AA) from human gastric juice protein. Studied for interactions with NO systems, growth factor signalling, and the FAK-paxillin pathway (Sikiric et al., 2018).
TB-500: A synthetic heptapeptide fragment of Thymosin Beta-4 containing the actin-binding domain (LKKTETQ). Studied for cytoskeletal dynamics and cell motility (Goldstein et al., 2005).
Published Research
- Sikiric P et al. (2018) — Curr Pharm Des, 24(18):1952-1962.
- Goldstein AL et al. (2005) — Expert Opin Biol Ther, 5(8):1053-1069.
Citations for reference only. No therapeutic claims.
Regulatory Notice
Strictly for in-vitro laboratory investigation only. Not for human or veterinary use. BioCompounds UK makes no therapeutic claims.








1 review for Wolverine 40mg (BPC-157 / TB-500) — Research Grade